A SIRT7-dependent acetylation switch regulates early B cell differentiation and lineage commitment through Pax5.

Area of Science:

• Immunology
• Molecular Biology
• Biochemistry

Background:

• B lymphopoiesis relies on transcription factors like Pax5 for lineage commitment.
• Pax5 is frequently altered in B cell acute lymphoblastic leukemia (B-ALL).
• Mechanisms regulating Pax5 function are not fully understood.

Purpose of the Study:

• To investigate the regulatory mechanisms of Pax5 during B cell development.
• To explore the role of SIRT7 in B lymphopoiesis and Pax5 regulation.
• To assess the clinical relevance of the SIRT7-Pax5 interaction in B-ALL.

Main Methods:

• Investigated the deacetylation of Pax5 by SIRT7 at K198.
• Utilized Pax5 K198 acetylation/deacetylation mimic mutants.
• Analyzed B cell differentiation and lineage commitment in knockout models (Pax5-/- and Sirt7-/-).
• Correlated SIRT7 expression with prognosis in B-ALL patient samples.

Main Results:

• SIRT7 deacetylates Pax5 at K198, enhancing its stability and transcriptional activity.
• Dynamic deacetylation of Pax5 is essential for B cell development.
• A Pax5 K198 deacetylation mimic restored lineage commitment in Pax5-/- cells and B cell differentiation in Sirt7-/- cells.
• SIRT7 expression correlates with favorable prognosis in B-ALL.

Conclusions:

• SIRT7-mediated Pax5 deacetylation is a critical regulator of B lymphopoiesis.
• The SIRT7-Pax5 axis plays a conserved role in B-ALL.
• Sirtuins are relevant to immune function and B-ALL prognosis.